Search results for "weight-loss drug"

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.6% in Phase 3 clinical trials, though it did...
Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs

Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs

As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop next-generation successors to blockbusters...
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1...
GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use

GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use

A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications...
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack

The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack

New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s...
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...
'Natural Wegovy' Is a Myth, Surgeon Warns, Pushing Back on Viral Diet Trend

'Natural Wegovy' Is a Myth, Surgeon Warns, Pushing Back on Viral Diet Trend

A viral social media trend promoting a "Natural Wegovy" diet—eating boiled eggs drizzled with olive oil—has prompted a...